Participants will be randomly assigned to the experimental and control groups. The study will involve a total of 78 participants, with 39 in the experimental group and 39 in the control group. The 39 participants assigned to the experimental group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales. They will then receive cancer education consisting of four modules, which will be completed over four weeks. At the end of these four weeks, they will complete the scales again. One month after the education, the experimental group will complete the scales once more for follow-up monitoring. The control group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales after agreeing to participate in the study. They will complete the scales again one month later. The evaluation of the education in the experimental group will involve comparing the scales completed before and after the education.
Individuals who agree to participate in the study, are aged 30-70,
Are literate,
Do not have any auditory, visual, cognitive, or orthopedic disabilities that would prevent participation,
Are not receiving palliative care services, will be included. This includes caregivers of cancer patients.
Individuals under the age of 30 or over the age of 70,
Those who are illiterate,
Those with disabilities that would prevent participation in the study,
Those who provide care for cancer patients receiving palliative care services will not be included in the study.
Parallel
Cancer education
Other interventionParticipants in the experimental group will receive cancer education.
İnformation Towards Cancer Screening Scale
The scale consists of 15 items and is unidimensional. It is a five-point Likert scale. The items on the scale are answered on a range from 1 to 5 as follows: \"5: Strongly agree, 4: Agree, 3: Neither agree nor disagree, 2: Disagree, 1: Strongly disagree.\" The scale is suitable for use with men and women aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic disabilities that would prevent them from answering the scale. The administration method of the scale should be such that the researcher observes the participant, and the participant reads and answers the scale items independently. The scale can be used in any situation where it is necessary to measure attitudes towards cancer screenings, provided that the appropriate sample and administration method are used. The lowest possible score on the scale is 15 and the highest is 75. There is no specific cutoff point for the scale. Scores close to 15 indicate
Cancer Knowledge Burden
Cancer information overload was measured using a thirteen- item battery assessing feelings about the overwhelming quantity of cancer information. Four response options (strongly disagree to strongly agree) were provided for each item (i.e., higher scores for greater overload). Items were crafted based on HINTS questions, an explication of the construct (detailed in the literature review of this article), and formative research conducted by the authors.
Attitudes Towards Cancer Screening Scale
The scale consists of 24 items and is unidimensional. It is a five-point Likert scale. The items on the scale are answered on a range from 1 to 5 as follows: \"5: Strongly agree, 4: Agree, 3: Neither agree nor disagree, 2: Disagree, 1: Strongly disagree.\" The scale is suitable for use with men and women aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic disabilities that would prevent them from answering the scale. The administration method of the scale should be such that the researcher observes the participant, and the participant reads and answers the scale items independently. The scale can be used in any situation where it is necessary to measure attitudes towards cancer screenings, provided that the appropriate sample and administration method are used. The lowest possible score on the scale is 24 and the highest is 120. There is no specific cutoff point for the scale. Scores close to 24 indicat
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
